Travere Therapeutics, Inc. (TVTX) › Total AssetsTravere Therapeutics, Inc. (TVTX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $19.6K2012: $2.39M2013: $20.50M2014: $135.47M2015: $512.26M2016: $525.28M2017: $520.35M2018: $709.16M2019: $604.80M2020: $607.44M2021: $776.63M2022: $672.59M2023: $788.91M2024: $594.12M2025: $605.19M$605.19M2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$605.19M+1.9%2024$594.12M-24.7%2023$788.91M+17.3%2022$672.59M-13.4%2021$776.63M+27.9%2020$607.44M+0.4%2019$604.80M-14.7%2018$709.16M+36.3%2017$520.35M-0.9%2016$525.28M+2.5%2015$512.26M+278.1%2014$135.47M+560.9%2013$20.50M+757.2%2012$2.39M+12119.0%2011$19.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share